Cargando…

Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: a meta-analysis of randomized clinical trials

BACKGROUND: Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits both interleukin (IL)-17A and IL-17F, and is a promising drug for patients with moderate-to-severe plaque psoriasis. OBJECTIVES: This study aimed to assess the efficacy and safety of bimekizumab in treating patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuqian, Li, Sheng, Bai, Juan, Cai, Xiaoxuan, Tang, Shunli, Lin, Peiyi, Sun, Qingmiao, Qiao, Jianjun, Fang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084576/ https://www.ncbi.nlm.nih.gov/pubmed/37051072 http://dx.doi.org/10.1177/20406223231163110

Ejemplares similares

Bimekizumab for plaque psoriasis
Publicado: (2022)

Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis
por: Pan, Ran, et al.
Publicado: (2022)

Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives
por: Camiña-Conforto, Gemma, et al.
Publicado: (2023)

Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis
por: Armstrong, April, et al.
Publicado: (2022)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi, Andrea, et al.
Publicado: (2019)

Risk factors of cardiovascular involvement in patients with Behcet's disease
por: Wang, Yuqian, et al.
Publicado: (2023)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Publicado: (2019)

Review of bimekizumab in the treatment of psoriasis
por: Koppu, Sindhuja, et al.
Publicado: (2022)

Association between serum visfatin levels and psoriasis and their correlation with disease severity: a meta-analysis
por: Zou, Qian, et al.
Publicado: (2021)

Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials
por: Gordon, Kenneth B., et al.
Publicado: (2022)

Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis
por: Bai, Fan, et al.
Publicado: (2017)

Effectiveness and safety of different doses of pioglitazone in psoriasis: a meta-analysis of randomized controlled trials
por: Zhang, Jing-Zhan, et al.
Publicado: (2020)

Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis
por: Zhou, Hang, et al.
Publicado: (2020)

Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis
por: Yang, Yanliang, et al.
Publicado: (2017)

Bimekizumab: the new drug in the biologics armamentarium for psoriasis
por: Freitas, Egídio, et al.
Publicado: (2021)

Efficacy and safety of tofacitinib for the treatment of chronic plaque psoriasis: a systematic review and meta-analysis
por: Tian, Fangyuan, et al.
Publicado: (2019)

Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐blind multicentre study
por: Oliver, R., et al.
Publicado: (2021)

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Cytokine Modulators in Plaque Psoriasis – A Review of Current and Prospective Biologic Therapeutic Approaches
por: Strychalski, Marisa L., et al.
Publicado: (2022)

Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose–response meta-analysis of prospective studies
por: Aune, Dagfinn, et al.
Publicado: (2018)

Efficacy and safety of baricitinib in patients with refractory alopecia areata
por: Wang, Yuqian, et al.
Publicado: (2022)

Can peripheral blood be used as surrogate in detecting epidermal growth factor receptor mutation status in advanced non-small cell lung cancer patients? A meta-analysis
por: Mao, Xiaowei, et al.
Publicado: (2017)

Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) versus low PEEP on patients with moderate–severe acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Zheng, Xi, et al.
Publicado: (2019)

Association between metabolic syndrome and psoriasis: a meta-analysis of observational studies with non-psoriasis control groups
por: Qiao, Ju, et al.
Publicado: (2020)

Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody–associated disease: a systematic review and meta-analysis
por: Lai, Qi-Lun, et al.
Publicado: (2021)

Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data
por: Vecchis, Renato De, et al.
Publicado: (2016)

A case of scalp psoriasis resistant to ixekizumab treated with bimekizumab
por: Megna, Matteo, et al.
Publicado: (2023)

Network meta-analysis of the efficacy and adverse effects of several treatments for advanced/metastatic prostate cancer
por: Wu, Jing, et al.
Publicado: (2017)

Evaluation of the Clinical Efficacy of Stem Cell Transplantation in the Treatment of Spinal Cord Injury: A Systematic Review and Meta-analysis
por: Tang, Qiao-Rui, et al.
Publicado: (2021)

Comparative short-term risks of infection and serious infection in patients receiving biologic and small-molecule therapies for psoriasis and psoriatic arthritis: a systemic review and network meta-analysis of randomized controlled trials
por: Chiu, Hsien-Yi, et al.
Publicado: (2023)

Efficacy and safety of argatroban in treatment of acute ischemic stroke: A meta-analysis
por: Lv, Bin, et al.
Publicado: (2022)

Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study
por: Asahina, Akihiko, et al.
Publicado: (2023)

Effects of exercise-based pulmonary rehabilitation on severe/very severe COPD: a systematic review and meta-analysis
por: He, Wenqing, et al.
Publicado: (2023)

The effect of statins on psoriasis severity: a meta-analysis of randomized clinical trials
por: Socha, Mateusz, et al.
Publicado: (2019)

Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis
por: Bai, Xue-Song, et al.
Publicado: (2022)

Percutaneous left ventricular assist device vs. intra-aortic balloon pump in patients with severe left ventricular dysfunction undergoing cardiovascular intervention: A meta-analysis
por: Hu, Fang-Bin, et al.
Publicado: (2018)

Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis
por: Zhan, Qiao-Hui, et al.
Publicado: (2017)

Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
por: Shang, Jin, et al.
Publicado: (2017)

Helicobacter pylori Infection is Associated with Occurrence of Proteinuria in Type 2 Diabetes Patients: A Systemic Review and Meta-Analysis
por: Shi, Yan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fp723enosnj081svnbfi1j7ju6